ENHANCED DIAGNOSIS OF ACANTHAMOEBA KERATITIS

棘阿米巴角膜炎的增强诊断

基本信息

  • 批准号:
    2711206
  • 负责人:
  • 金额:
    $ 1.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-07-01 至 1998-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: Acanthamoeba keratitis has been considered a relatively rare and severe form of corneal infection which causes debilitating visual loss. It has most frequently been associated with the use of contact lenses. The diagnosis is confirmed with a simple epithelial biopsy and histologic examination by an ophthalmic pathologist. In the last three years, we have examined 400 patients with keratitis and have identified 106 patients with presumed Acanthamoeba in the cornea, each subsequently confirmed with an epithelial biopsy. In only one case have we been successful in culturing the organism. It is the PI general hypothesis that Acanthamoeba keratitis represents an underdiagnosed opportunistic infection of the human cornea which can present a significant health hazard. It is much more common than previously thought. The diagnosis and management of this disease will be greatly improved with more precise and rapid diagnostic tools including confocal microscopy and polymerase chain reaction (PCR). We propose in this research to: 1) Determine the prevalence of subclinical or asymptomatic Acanthamoeba infection in the normal population by examining, with confocal microscopy, a series of normal patients and patients undergoing epithelial removal prior to PRK for myopia. Examine Eye Bank eyes with confocal microscopy, histology, and PCR for the presence of amoeba. 2) Determine the prevalence of clinical, subclinical, or asymptomatic corneal acanthamoeba infections in patients with various forms of keratopathy including presumed bacterial keratitis, diabetic epitheliopathy, basement membrane dystrophy, herpes simplex keratitis and herpes zoster keratitis and confirm the diagnosis with histology, culture and PCR. 3) Determine the prevalence of clinical or subclinical acanthamoeba infection in patients particularly prone to acute infection including patients wearing contact lenses who have normal epithelium or evidence of epithelial disease such as punctate keratitis or microcysts. Patients with clinical and confocal evidence of disease will have an epithelial biopsy for further diagnosis. 4) Characterize the organisms we have identified by developing a polymerase chain reaction (PCR) assay, enhance our culture techniques, and thereby characterize more precisely these organisms.
描述:棘阿米巴角膜炎被认为是一种相对罕见的疾病。 以及严重的角膜感染,导致视力下降。 它最常与隐形眼镜的使用联系在一起。这个 诊断是通过简单的上皮活检和组织学来确认的 由眼科病理学家进行的检查。在过去的三年里,我们有 检查了400名角膜炎患者,确定了106名患者 推测角膜中有棘阿米巴,每一种后来都用 上皮活组织检查。我们只在一个案例中成功地培养了 有机体。棘阿米巴角膜炎是PI的普遍假设 代表一种诊断不足的人类角膜机会性感染 这可能会对健康造成重大危害。它比 之前的想法是。这种疾病的诊断和治疗将是 通过更精确、更快速的诊断工具大幅改进,包括 共聚焦显微镜和聚合酶链式反应(PCR)。我们在此提出建议 研究:1)确定亚临床或无症状的患病率 共聚焦检测正常人群棘阿米巴感染 显微镜下,一系列正常患者和上皮下病变患者 近视PRK前摘除。共焦检查眼库眼 显微镜、组织学和聚合酶链式反应检测阿米巴的存在。2)确定 临床、亚临床或无症状角膜棘阿米巴的患病率 各种形式的角膜病变患者的感染,包括假定的 细菌性角膜炎,糖尿病上皮病变,基底膜营养不良, 单纯疱疹病毒性角膜炎和带状疱疹角膜炎 组织学、培养和聚合酶链式反应诊断。3)确定 临床或亚临床棘阿米巴感染 容易受到急性感染,包括戴隐形眼镜的患者 正常的上皮或上皮病的证据,如点状 角膜炎或微囊。有临床和共聚焦证据的患者 该病将进行上皮活检以作进一步诊断。4) 通过开发一种聚合酶来表征我们已经鉴定的生物 链式反应(PCR)分析,提高我们的培养技术,从而 更准确地描述这些有机体的特征。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM D MATHERS其他文献

WILLIAM D MATHERS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM D MATHERS', 18)}}的其他基金

In Vivo Imaging of Leukocyte-Endothelial Dynamics
白细胞内皮动力学的体内成像
  • 批准号:
    6614375
  • 财政年份:
    2003
  • 资助金额:
    $ 1.74万
  • 项目类别:
In Vivo Imaging of Leukocyte-Endothelial Dynamics
白细胞内皮动力学的体内成像
  • 批准号:
    6732733
  • 财政年份:
    2003
  • 资助金额:
    $ 1.74万
  • 项目类别:
In Vivo Imaging of Leukocyte-Endothelial Dynamics
白细胞内皮动力学的体内成像
  • 批准号:
    6874846
  • 财政年份:
    2003
  • 资助金额:
    $ 1.74万
  • 项目类别:
ENHANCED DIAGNOSIS OF ACANTHAMOEBA KERATITIS
棘阿米巴角膜炎的增强诊断
  • 批准号:
    2020181
  • 财政年份:
    1997
  • 资助金额:
    $ 1.74万
  • 项目类别:
ENHANCED DIAGNOSIS OF ACANTHAMOEBA KERATITIS
棘阿米巴角膜炎的增强诊断
  • 批准号:
    6038248
  • 财政年份:
    1997
  • 资助金额:
    $ 1.74万
  • 项目类别:
TEAR FUNCTION IN BLEPHARITIS AND DRY EYE
睑缘炎和干眼症的泪液功能
  • 批准号:
    6164679
  • 财政年份:
    1992
  • 资助金额:
    $ 1.74万
  • 项目类别:
MEIBOMIAN GLAND DYSFUNCTION IN CHRONIC BLEPHARITIS
慢性睑缘炎的睑板腺功能障碍
  • 批准号:
    2163864
  • 财政年份:
    1992
  • 资助金额:
    $ 1.74万
  • 项目类别:
TEAR FUNCTION IN BLEPHARITIS AND DRY EYE
睑缘炎和干眼症的泪液功能
  • 批准号:
    6038247
  • 财政年份:
    1992
  • 资助金额:
    $ 1.74万
  • 项目类别:
MEIBOMIAN GLAND DYSFUNCTION IN CHRONIC BLEPHARITIS
慢性睑缘炎的睑板腺功能障碍
  • 批准号:
    3267372
  • 财政年份:
    1992
  • 资助金额:
    $ 1.74万
  • 项目类别:
TEAR FUNCTION IN BLEPHARITIS AND DRY EYE
睑缘炎和干眼症的泪液功能
  • 批准号:
    2608653
  • 财政年份:
    1992
  • 资助金额:
    $ 1.74万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.74万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 1.74万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 1.74万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 1.74万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 1.74万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 1.74万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 1.74万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 1.74万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 1.74万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 1.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了